1 August 2017 | European support for rapidly advancing vaccine development
European Commission renews funding to support vaccine innovation via European research infrastructure
TRANSVAC2_PR project start_Final_170731
Navigation
Business
Contact
Dr. ir. Sven Arnouts / Business Developer
Center for Strategic Prophylaxis and Vaccine Development - PROVAXS
Ghent University / Faculty of Veterinary Medicine
Department of Virology, Parasitology and Immunology
Salisburylaan 133, 9820 Merelbeke, Belgium
Tel. : +32 495.707.334
Sven.Arnouts@UGent.be
Realisatie en beheer UCS bvba
